Skip to content
Lower risk Medical device recall · FDA · Published October 5, 2023

Encore Medical Reverse Shoulder System e+ Recall: Mislabeling Hazard

Encore Medical recalls Reverse Shoulder System e+ (REF 509-01-032) due to mislabeling. Affected units have specific UDI and lot numbers. No action needed per recall details.

🇺🇸 FDA recall #Z-0625-2024Medical deviceEncore Medical ›
Take action

Contact the company

Recalling firmEncore Medical, LP9800 Metric Blvd · Austin, TX 78758-5445
✎ GovInfoNow plain-language explainer

What happened, in plain English

Encore Medical is recalling a specific Reverse Shoulder System e+ implant due to mislabeling. This means the product may not be correctly identified, which could lead to improper use or complications during surgery. Affected units have a unique device identifier and specific lot numbers. Read more at govinfonow.com/recall/57149-encore-medical-reverse-shoulder-system-e-recall-mislabeling-hazard.

Source Summary by GovInfoNow · govinfonow.com/recall/57149-encore-medical-reverse-shoulder-system-e-recall-mislabeling-hazard · Updated August 19, 2026 · FDA enforcement record: FDA #Z-0625-2024

Cite this page

“Encore Medical Reverse Shoulder System e+ Recall: Mislabeling Hazard.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/57149-encore-medical-reverse-shoulder-system-e-recall-mislabeling-hazard. Based on FDA recall #Z-0625-2024 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0625-2024%22&limit=1).

Why it’s dangerous

Mislabeling can cause the implant to be incorrectly identified, potentially leading to improper surgical procedures or complications. This risk is specific to the product's intended use in medical procedures.

Who’s affected

Patients who received the Reverse Shoulder System e+ implant with the specified UDI and lot numbers are affected. Surgeons and medical staff using this product are at risk if they use mislabeled units.

How to tell if you have this one

Check for the unique device identifier (UDI) (01)00888912144612 and lot number 381P1167 on the product packaging. The product is labeled as Reverse Shoulder System e+ (REF 509-01-032), RSP Humeral Socket Insert, Sz. 32mm, Semi-Constrained, Sterile H2o2, CE 2797.

  • Brand
    Encore Medical
  • Product
    Reverse Shoulder System e+, REF 509-01-032, RSP Humeral Socket Insert, Sz. 32mm, Semi-Constrained, Sterile H2o2, CE 2797
  • Category
    Medical device
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Completed
  • Distribution
    US Nationwide distribution in the states of VA, TN, MN, IN, RI, ME, TX, LA, AL, FL, CA.
Recall numberProduct, codes & lotsQuantity
Z-0625-2024Reverse Shoulder System e+, REF 509-01-032, RSP Humeral Socket Insert, Sz. 32mm, Semi-Constrained, Sterile H2o2, CE 2797; UDI: (01)00888912144612/Lot Number(s): 381P116717 units
Z-0626-2024REF 130-03-738, All-Poly e + Patella, Domed Tri-Peg, 9x38mm, STERILE H2O2; UDI: (01)00888912108560/Lot Number(s): 157N15562 units
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the unique device identifier (UDI) (01)00888912144612 and lot number 381P1167 on the product packaging.

Where it went and when

Where it was distributed

Distributed nationwide; the notice names 11 states.

Alaska: nationwideAKMaine: named in the noticeMEVermont: nationwideVTNew Hampshire: nationwideNHWashington: nationwideWAIdaho: nationwideIDMontana: nationwideMTNorth Dakota: nationwideNDMinnesota: named in the noticeMNIllinois: nationwideILWisconsin: nationwideWIMichigan: nationwideMINew York: nationwideNYRhode Island: named in the noticeRIMassachusetts: nationwideMAOregon: nationwideORNevada: nationwideNVWyoming: nationwideWYSouth Dakota: nationwideSDIowa: nationwideIAIndiana: named in the noticeINOhio: nationwideOHPennsylvania: nationwidePANew Jersey: nationwideNJConnecticut: nationwideCTCalifornia: named in the noticeCAUtah: nationwideUTColorado: nationwideCONebraska: nationwideNEMissouri: nationwideMOKentucky: nationwideKYWest Virginia: nationwideWVVirginia: named in the noticeVAMaryland: nationwideMDDelaware: nationwideDEArizona: nationwideAZNew Mexico: nationwideNMKansas: nationwideKSArkansas: nationwideARTennessee: named in the noticeTNNorth Carolina: nationwideNCSouth Carolina: nationwideSCDistrict of Columbia: nationwideDCOklahoma: nationwideOKLouisiana: named in the noticeLAMississippi: nationwideMSAlabama: named in the noticeALGeorgia: nationwideGAHawaii: nationwideHITexas: named in the noticeTXFlorida: named in the noticeFL

FDA distribution: “US Nationwide distribution in the states of VA, TN, MN, IN, RI, ME, TX, LA, AL, FL, CA.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, California, Florida, Indiana, Louisiana, Maine, Minnesota, Rhode Island, Tennessee, Texas, Virginia.

Recall timeline

FDA published this recall 3 months after the firm started it.

1. Firm started the recall: Oct 5, 202312. FDA classified it Class II: Jan 2, 202423. Published in FDA’s Enforcement Report: Jan 10, 2024320232024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is there a risk of serious injury from this mislabeling?

The recall is for mislabeling, which could lead to improper use during surgery. However, the hazard is not described as causing serious injury in normal use, so the risk is low.

Do I need to stop using this product?

No action is required per the recall details. The product is safe to use if it has the correct UDI and lot number.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0625-2024 (October 5, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0625-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA